Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

HBIO

Harvard Bioscience Inc

Feb 10 • 04:00PM ET

0.6010

+0.0709 13.37 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Feb 10, 7:35 AMHarvard Bioscience issues preliminary Q4 2025 results showing $23.7 million in revenue, 27% adjusted EBITDA growth, and forecasts year-over-year revenue and mid- to high-single-digit adjusted EBITDA growth for 2026 while outlining new long-term strategic pillars.

Peers: TMO DHR BIO A MTD ILMN QGEN TECH RGEN WAT

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.22	Insider Own	5.81%	Shs Outstand	44.58M	Perf Week	20.18%
Market Cap	26.88M	Forward P/E	6.33	EPS next Y	0.10	Insider Trans	0.00%	Shs Float	42.12M	Perf Month	-4.66%
Enterprise Value	62.84M	PEG	0.07	EPS next Q	0.04	Inst Own	42.18%	Short Float	1.39%	Perf Quarter	10.66%
Income	-53.84M	P/S	0.31	EPS this Y	0.00%	Inst Trans	-8.50%	Short Ratio	0.87	Perf Half Y	25.47%
Sales	87.37M	P/B	1.90	EPS next Y	216.67%	ROA	-51.46%	Short Interest	0.59M	Perf YTD	-10.14%
Book/sh	0.32	P/C	3.94	EPS next 5Y	88.21%	ROE	-135.62%	52W High	1.49 -59.66%	Perf Year	-57.38%
Cash/sh	0.15	P/FCF	3.98	EPS past 3/5Y	-242.36% -18.10%	ROIC	-251.57%	52W Low	0.28 113.65%	Perf 3Y	-81.22%
Dividend Est.	-	EV/EBITDA	13.46	Sales past 3/5Y	-7.49% -4.12%	Gross Margin	51.87%	Volatility	10.06% 7.84%	Perf 5Y	-87.35%
Dividend TTM	-	EV/Sales	0.72	EPS Y/Y TTM	-271.93%	Oper. Margin	-1.83%	ATR (14)	0.05	Perf 10Y	-79.13%
Dividend Ex-Date	-	Quick Ratio	0.41	Sales Y/Y TTM	-10.60%	Profit Margin	-61.62%	RSI (14)	54.09	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.81	EPS Q/Q	74.93%	SMA20	8.31%	Beta	1.55	Target Price	2.00
Payout	-	Debt/Eq	3.04	Sales Q/Q	-6.28%	SMA50	-7.48%	Rel Volume	8.10	Prev Close	0.53
Employees	355	LT Debt/Eq	0.52	Earnings	Nov 06 BMO	SMA200	16.97%	Avg Volume	671.43K	Price	0.60
IPO	Dec 07, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-100.00% 2.96%	Trades		Volume	5,441,112	Change	13.37%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-10-23	Upgrade	The Benchmark Company	Speculative Buy → Buy	$3 → $4
Jan-07-21	Upgrade	The Benchmark Company	Speculative Buy → Buy
Dec-09-20	Initiated	Northland Capital	Outperform	$6
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$6
Jul-08-19	Downgrade	Janney	Buy → Neutral	$2
Jan-24-18	Reiterated	Janney	Buy	$5 → $8
Jan-23-18	Reiterated	The Benchmark Company	Buy	$6 → $10
Nov-17-16	Initiated	Singular Research	Buy	$5.50
Jul-28-15	Initiated	The Benchmark Company	Buy	$8

Feb-10-26 07:30AM	Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas (GlobeNewswire) +13.37%
Feb-03-26 05:35AM	Harvard Bioscience will move Holliston MA manufacturing out of state (The Metrowest Daily News)
Jan-30-26 06:49AM	Harvard Bioscience Trims Footprint To Run Leaner, Faster, And Cheaper (Benzinga) -6.65%
Jan-29-26 04:30PM	Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth (GlobeNewswire) -6.29%
Dec-17-25 07:30AM	Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package (GlobeNewswire) +12.43%
02:05PM	Loading…
Nov-06-25 02:05PM	Harvard Bioscience Inc (HBIO) Q3 2025 Earnings Call Highlights: Strong Margins and Strategic ... (GuruFocus.com) -7.29%
07:31AM	Harvard Bioscience: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Harvard Bioscience Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-30-25 08:00AM	Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET (GlobeNewswire) +41.10%
Sep-16-25 07:00AM	Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States (GlobeNewswire) +10.33%
Sep-09-25 07:00AM	Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors (GlobeNewswire)
Aug-12-25 03:02AM	Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Aug-11-25 07:20AM	Harvard Bioscience: Q2 Earnings Snapshot (Associated Press Finance) -9.25%
07:00AM	Harvard Bioscience Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-08-25 09:33AM	Earnings To Watch: Harvard Bioscience Inc (HBIO) Reports Q2 2025 Result (GuruFocus.com)
04:30PM	Loading…
Aug-04-25 04:30PM	Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET (GlobeNewswire) +10.89%
Jul-17-25 07:00AM	Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board (GlobeNewswire) +12.07%
Jun-02-25 04:57PM	Harvard Bioscience Appoints John Duke to Board of Directors (GlobeNewswire) -13.19%
May-14-25 09:14AM	Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark (TipRanks) -6.66%
May-13-25 03:03AM	Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) +5.25%
May-12-25 11:28PM	Q1 2025 Harvard Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) +11.78%
07:13AM	Harvard Bioscience: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Harvard Bioscience Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-09-25 09:52AM	Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
May-05-25 04:45PM	Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET (GlobeNewswire) -5.12% -9.06%
Apr-10-25 04:45PM	Harvard Bioscience Announces CFO Transition (GlobeNewswire) -15.97%
Mar-13-25 01:18AM	Q4 2024 Harvard Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) -6.55%
Mar-12-25 04:00PM	Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 (GlobeNewswire) -10.10%
07:21AM	Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results (GlobeNewswire)
Feb-24-25 04:45PM	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting (GlobeNewswire) -6.00% -6.52%
11:00AM	Loading…
11:00AM	Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET (GlobeNewswire)
Jan-21-25 09:00AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-13-25 05:52PM	Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference (GlobeNewswire)
Nov-08-24 02:08AM	Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com) +7.53%
Nov-07-24 07:12AM	Harvard Bioscience: Q3 Earnings Snapshot (Associated Press Finance) -15.25%
07:00AM	Harvard Bioscience Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:50AM	Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com) +17.99%
Oct-29-24 05:00PM	Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET (GlobeNewswire)
Oct-09-24 05:43PM	Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Oct-03-24 08:00AM	Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 (GlobeNewswire)
Sep-18-24 07:30AM	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting (GlobeNewswire) -5.44%
Sep-17-24 08:00AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Sep-05-24 04:05PM	Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference (GlobeNewswire)
Aug-08-24 08:37AM	Harvard Bioscience: Q2 Earnings Snapshot (Associated Press Finance) +11.83%
08:30AM	Harvard Bioscience Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-02-24 08:00AM	Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET (GlobeNewswire)
Jun-06-24 04:05PM	Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 (GlobeNewswire)
May-23-24 04:05PM	Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 (GlobeNewswire)
May-16-24 04:05PM	Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference (GlobeNewswire)
May-08-24 10:14AM	Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:03AM	Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-07-24 11:56AM	HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:41AM	Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments (GuruFocus.com)
08:15AM	Harvard Bioscience (HBIO) Q1 Earnings Match Estimates (Zacks)
07:13AM	Harvard Bioscience: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Harvard Bioscience Announces First Quarter 2024 Financial Results (GlobeNewswire)
Apr-29-24 08:45AM	Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET (GlobeNewswire)
Apr-09-24 09:00AM	Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth (GlobeNewswire) +7.42%
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-11-24 08:00AM	Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference (GlobeNewswire)
Mar-08-24 10:48AM	Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-07-24 10:51PM	Q4 2023 Harvard Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) +9.73%
01:56PM	Harvard Bioscience Inc (HBIO) Reports Mixed Fourth Quarter and Full Year 2023 Results (GuruFocus.com)
12:53PM	HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:32AM	Harvard Bioscience: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Harvard Bioscience Announces Fourth Quarter 2023 Financial Results (GlobeNewswire)
Mar-06-24 08:30AM	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting (GlobeNewswire)
Feb-27-24 05:10PM	Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET (GlobeNewswire)
Nov-20-23 04:40PM	Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023 (GlobeNewswire)
Nov-09-23 04:30PM	Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023 (GlobeNewswire)
02:28PM	Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 09:58PM	Q3 2023 Harvard Bioscience Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	Harvard Bioscience Inc (HBIO) Reports Q3 2023 Earnings: Gross Margin Expands Amid Revenue Decline (GuruFocus.com)
07:28AM	Harvard Bioscience: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Harvard Bioscience Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-06-23 04:30PM	Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023 (GlobeNewswire)
Oct-30-23 09:00AM	Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET (GlobeNewswire)
Sep-18-23 08:57AM	Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research (GlobeNewswire)
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE) +6.00%
Aug-08-23 09:43PM	Q2 2023 Harvard Bioscience Inc Earnings Call (Thomson Reuters StreetEvents)
09:15AM	Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates (Zacks)
08:05AM	Harvard Bioscience: Q2 Earnings Snapshot (AP Finance)
07:18AM	Harvard Bioscience Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 06:30PM	Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023 (GlobeNewswire) +5.69%
Jul-27-23 06:36PM	Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET (GlobeNewswire)
Jun-22-23 07:55AM	Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes (GlobeNewswire)
Jun-21-23 08:50AM	Here's Why Momentum in Harvard Bioscience (HBIO) Should Keep going (Zacks)
Jun-20-23 08:01AM	Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer (GlobeNewswire) +10.02%
Jun-13-23 12:21PM	Harvard Bioscience, Inc. (NASDAQ:HBIO) is largely controlled by institutional shareholders who own 61% of the company (Simply Wall St.)
May-25-23 08:50AM	Here's What Could Help Harvard Bioscience (HBIO) Maintain Its Recent Price Strength (Zacks)
May-24-23 08:26AM	5 High-Flying Tech Stocks With Solid Growth Potential (Zacks)
May-23-23 10:17AM	Harvard Bioscience Insiders Placed Bullish Bets Worth US$694k \ (Simply Wall St.)
May-09-23 09:40AM	Harvard Bioscience, Inc. (NASDAQ:HBIO) Soars 39% But It's A Story Of Risk Vs Reward (Simply Wall St.)
08:50AM	What Makes Harvard Bioscience (HBIO) a Good Fit for 'Trend Investing' (Zacks)
07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE)
May-02-23 05:01PM	Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023 (GlobeNewswire)
08:35AM	Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2023 Earnings Call Transcript (Insider Monkey)
Apr-27-23 06:14PM	Why Harvard Bioscience Stock Rose This Week (Motley Fool)
Apr-26-23 12:02AM	Q1 2023 Harvard Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) +6.48%
Apr-25-23 08:41AM	Those who invested in Harvard Bioscience (NASDAQ:HBIO) three years ago are up 82% (Simply Wall St.) +7.14%

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HBIO

Harvard Bioscience Inc

Upgrade your FINVIZ experience